Date of publication: April 11,
2006
Source:
http://gmoinfo.jrc.it/gmp_browse_geninf.asp
Notification number:
B/FR/06/03/01
Member State:France
Date of Acknowledgement:20/02/2006
Title of the Project: Application for the deliberate
release of genetically modified MON-ØØ6Ø3-6xMON-ØØ81Ø-6
(NK603xMON810) maize
Proposed period of release From:01/04/2006
To:31/12/2009
Name of the Institute(s) or Company(ies): Pioneer
Genetique;
3. Is the same GMPt release planned elsewhere in the
Community?
No
4 - Has the same GMPt been notified elsewhere by the same
notifier?
No
Genetically
modified plant
1. Complete name of the
recipient or parental plant(s)
|
Common Name
|
Family Name
|
Genus |
Species
|
Subspecies
|
Cultivar/breeding line
|
| maize
|
poaceae |
zea
|
zea
mays |
mays
|
experimental varieties |
2. Description of the traits and characteristics which have
been introduced or modified, including marker genes and previous
modifications:
The genetically modified NK603xMON810 maize varieties that
will be tested in these field trials can tolerate the use of
glyphosate herbicide for the weeding of maize field and are
resistant to certain Lepidopteran insect pests such as the
European corn borer (Ostrinia nubilalis). This maize was derived
through traditional breeding methods between progeny of the
genetically modified NK603 maize (from Monsanto), which is
tolerant to glyphosate herbicide, and MON810 maize (from
Monsanto), which is resistant to certain lepidopteran insects.
Genetic
modification
3. Type of genetic
modification:
Insertion;
4. In case of insertion of genetic material, give the source
and intended function of each constituent fragment of the region
to be inserted:
The genes introduced in NK603xMON810 maize are the cp4epsps
gene from Agrobacterium sp. strain CP4 that confers tolerance to
glyphosate herbicide, like in NK603 maize, and the cry1Ab gene
from Bacillus thuringiensis subsp. kurstaki that confers
resistance to certain Lepidopteran insects such as Ostrinia
nubilalis, like in MON810 maize, along with the regulatory
components necessary for expression in maize plant:
- the cp4epsps gene, the P-ract1/ract1 intron + ctp2, the NOS 3’
terminator.
- the cp4epsps gene, the e35S promoter + Zmhsp70 + ctp2, the NOS
3’ terminator.
- the cry1Ab gene, the e35S promoter + Zmhsp70
6. Brief description of the method used for the genetic
modification:
No genetic modification was applied to obtain the
NK603xMON810 maize varieties directly: they were derived through
traditional breeding methods between progeny of the genetically
modified NK603 maize and MON810 maize.
NK603 maize and MON810 maize were genetically modified by
Monsanto using the particle acceleration method.
7. If the recipient or parental plant is a forest tree
species, describe ways and extent of dissemination and specific
factors affecting dissemination:
Not applicable
Experimental
Release
1. Purpose of the release:
The purpose of the release is to collect data on the
agronomic value and insect resistance of NK603xMON810 maize
varieties and to observe the plant behavior, which could enable
to collect morpho-physiological data.
2. Geographical location of the site:
The releases are planned at several locations in France
within the following areas: Nord-Pas-de-Calais (Nord), Picardie
(Aisne, Oise, Somme), Bourgogne (Saône et Loire), Rhône-Alpes
(Ain, Isère, Drome), Centre (Eure et Loir, Loir et Cher, Indre,
Indre et Loire, Loiret), Aquitaine (Landes, Lot et Garonne),
Midi-Pyrénées (Haute-Garonne, Gers, Tarn, Tarn et Garonne),
Languedoc-Roussillon (Aude).
3. Size of the site (m2):
Every year, there could have up to 12 sites of release, each
sown with up to 5000 m² of genetically modified NK603xMON810
maize subject of this notification. Other GMOs may be planted on
the same sites of release. Thus, the total trial surface for
each site (all varieties and borders included) will be larger.
4. Relevant data regarding previous releases carried out with
the same GM-plant, if any, specifically related to the potential
environmental and human health impacts from the release:
Many field trials have already been conducted at several
locations and no environmental problems were reported for these
trials. The transgenic plants behaved as conventional maize.
They were indistinguishable from the non-genetically modified
maize plants except for showing tolerance to glyphosate
herbicide and resistance to certain Lepidopteran insects such as
the European Corn Borer, traits due to the genetic
modifications.
Environmental
Impact and Risk Management
Summary of the potential
environmental impact from the release of the GMPts:
No risks to human and animal health or the environment from
the deliberate release of genetically modified NK603xMON810
maize tolerant to glyphosate herbicide and resistant to certain
Lepidopteran insects are expected, as per information contained
in the Summary Notification Information Format of notification
C/ES/04/01.
Brief description of any measures taken for the management of
risks:
The shedding of pollen from the genetically modified plants
will be controlled by maintaining a 200-meter isolation distance
with any other non-experimental maize crop. In addition, the
trial will be surrounded by four border rows of conventional
maize of a similar relative maturity that will be also destroyed
at the end of the release.
Seed dispersal of individual kernels does not generally occur.
They are fixed on a cob and enclosed in many husks that protect
the seeds from outside contact. When a few seeds need to be
collected for analysis; this will be done by sampling the whole
ear and unused seeds will be destroyed.
In case of any emergency, the trial could be stopped by
application of a non-selective herbicide, other than glyphosate,
or by mechanical destruction and incorporation into the soil.
At the end of the release, all remaining plant matter that has
not been harvested for analyses will be destroyed by chopping
and incorporating into the soil. No plant or plant product
coming from the trials will enter the food or feed chains.
Volunteer maize will be monitored during the following year in
order to ensure their destruction, if needed.
No commercial maize will be cultivated in the trial site the
following year.
Summary of foreseen field trial studies focused to gain new
data on environmental and human health impact from the release:
Not applicable to this release.
Final report
-
European
Commission administrative information
Consent given by the Competent
Authority: Not Known |
